Revenue vs Net income
Reported dollars from 10-Q / 10-K filings. Q4 bars are derived (annual less nine months) where the 10-K does not tag Q4 separately.
Margin trend
Gross, operating and net margin. Margins are derived from reported dollars.
Revenue YoY growth
Year-over-year change vs the same quarter (or fiscal year) a year earlier. Shown where the prior-year period is in the 8-quarter snapshot (latest four quarters).
Income statement
From 10-Q / 10-K XBRL. Values in reported dollars; EPS in $/share; share counts in shares.
| Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.5B | $9.1B | $8.1B | $9.2B | $9.6B | $9.9B | $8.6B | $10.1B |
| YoY | — | — | — | — | +12.4% | +8.6% | +5.8% | +9.5% |
| Cost of goods sold | $3.3B | $3.1B | $3.0B | $3.0B | $3.1B | $3.0B | $2.7B | $2.8B |
| YoY | — | — | — | — | -6.9% | -4.4% | -7.5% | -6.6% |
| Gross profit | — | — | — | — | — | — | — | — |
| YoY | — | — | — | — | — | — | — | — |
| Research & development | — | — | — | — | — | — | — | — |
| YoY | — | — | — | — | — | — | — | — |
| Selling, general & administrative | $1.6B | $1.9B | $1.7B | $1.7B | $1.7B | $2.0B | $1.6B | $1.7B |
| YoY | — | — | — | — | +5.8% | +3.9% | -5.0% | +3.2% |
| Operating income | $2.0B | $2.3B | $1.2B | $2.7B | $2.5B | $2.7B | $2.7B | $3.5B |
| YoY | — | — | — | — | +23.4% | +17.7% | +126.3% | +32.3% |
| Pretax income | — | — | — | — | — | — | — | — |
| YoY | — | — | — | — | — | — | — | — |
| Income tax | $271.0M | $155.0M | $243.0M | $136.0M | $705.0M | $181.0M | $265.0M | $393.0M |
| YoY | — | — | — | — | +160.1% | +16.8% | +9.1% | +189.0% |
| Net income | $2.8B | $627.0M | $1.7B | $1.4B | $3.2B | $1.3B | $1.8B | $2.4B |
| YoY | — | — | — | — | +13.6% | +112.6% | +5.1% | +65.9% |
| EPS — basic | $5.27 | — | $3.22 | $2.66 | $5.98 | — | $3.37 | $4.40 |
| YoY | — | — | — | — | +13.5% | — | +4.7% | +65.4% |
| EPS — diluted | $5.22 | — | $3.20 | $2.65 | $5.93 | — | $3.34 | $4.37 |
| YoY | — | — | — | — | +13.6% | — | +4.4% | +64.9% |
| Weighted shares — basic | 537.0M | — | 538.0M | 538.0M | 538.0M | — | 540.0M | 540.0M |
| Weighted shares — diluted | 542.0M | — | 541.0M | 541.0M | 542.0M | — | 544.0M | 544.0M |
Balance sheet
Point-in-time values at each quarter (or fiscal year) end.
| Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $9.0B | $12.0B | $8.8B | $8.0B | $9.4B | $9.1B | $12.0B | $14.0B |
| YoY | — | — | — | — | +4.8% | -23.8% | +36.6% | +74.3% |
| Marketable securities (current) | — | — | — | — | — | — | — | — |
| YoY | — | — | — | — | — | — | — | — |
| Accounts receivable | $7.3B | $6.8B | $8.1B | $8.7B | $8.5B | $9.6B | $9.1B | $10.2B |
| YoY | — | — | — | — | +16.0% | +41.1% | +12.4% | +17.5% |
| Inventory | $7.4B | $7.0B | $6.7B | $6.6B | $6.3B | $6.2B | $6.2B | $6.2B |
| YoY | — | — | — | — | -13.8% | -11.0% | -8.1% | -5.5% |
| Total current assets | $26.8B | $29.0B | $26.9B | $26.7B | $27.9B | $29.1B | $31.5B | $35.0B |
| YoY | — | — | — | — | +4.2% | +0.1% | +16.9% | +30.8% |
| Total assets | $90.9B | $91.8B | $89.4B | $87.9B | $90.1B | $90.6B | $92.5B | $95.6B |
| YoY | — | — | — | — | -0.8% | -1.4% | +3.5% | +8.8% |
| Total current liabilities | $20.3B | $23.1B | $23.0B | $20.5B | $21.8B | $25.5B | $25.0B | $25.5B |
| YoY | — | — | — | — | +7.3% | +10.3% | +8.5% | +24.5% |
| Total liabilities | — | — | — | — | — | — | — | — |
| YoY | — | — | — | — | — | — | — | — |
| Total equity | $7.5B | $5.9B | $6.2B | $7.4B | $9.6B | $8.7B | $9.2B | $11.7B |
| YoY | — | — | — | — | +27.8% | +47.3% | +48.1% | +57.4% |
| Shares outstanding | 537.5M | 536.9M | 537.7M | 538.3M | 538.5M | 538.8M | 539.7M | 540.6M |
| YoY | — | — | — | — | +0.2% | +0.4% | +0.4% | +0.4% |
Cash flow
Quarterly values derived from year-to-date filings (Q4 from the 10-K). Free cash flow = operating cash flow − capital expenditures.
| Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $3.6B | $4.8B | $1.4B | $2.3B | $4.7B | $1.6B | $2.2B | $4.0B |
| YoY | — | — | — | — | +31.2% | -66.4% | +57.4% | +75.5% |
| Capital expenditures | $257.0M | $371.0M | $411.0M | $369.0M | $436.0M | $642.0M | $712.0M | $513.0M |
| YoY | — | — | — | — | +69.6% | +73.0% | +73.2% | +39.0% |
| Free cash flow | $3.3B | $4.4B | $980.0M | $1.9B | $4.2B | $961.0M | $1.5B | $3.5B |
| YoY | — | — | — | — | +28.2% | -78.2% | +50.7% | +82.6% |
| Dividends paid | — | — | — | — | — | — | — | — |
| YoY | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| YoY | — | — | — | — | — | — | — | — |
Margins & ratios
Derived from the reported dollars above — no separate source.
| Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | 24.1% | 25.4% | 14.5% | 28.9% | 26.4% | 27.6% | 30.9% | 35.0% |
| Net margin | 33.3% | 6.9% | 21.2% | 15.6% | 33.7% | 13.5% | 21.1% | 23.6% |
| Free cash flow margin | 39.0% | 48.4% | 12.0% | 20.8% | 44.4% | 9.7% | 17.1% | 34.7% |
| Effective tax rate | — | — | — | — | — | — | — | — |
| Current ratio | 1.32x | 1.26x | 1.17x | 1.31x | 1.28x | 1.14x | 1.26x | 1.37x |
| Total liabilities / equity | — | — | — | — | — | — | — | — |
Peer comparison — latest full year
Same sector (Health Care), sorted by revenue. All figures from the same EDGAR XBRL snapshot.
| Ticker | Revenue | Revenue YoY | Gross margin | Operating margin | Net margin | FCF margin |
|---|---|---|---|---|---|---|
| AMGN FY25 · this stock | $36.8B | +10.0% | — | 24.7% | 21.0% | 22.0% |
| UNH FY25 | $447.6B | +11.8% | — | 4.2% | 2.7% | 3.6% |
| CVS FY25 | $402.1B | +7.8% | — | 1.2% | 0.4% | 1.9% |
| CI FY25 | $274.9B | +11.2% | — | 3.3% | — | — |
| ELV FY25 | $199.1B | +12.5% | — | 3.6% | 2.8% | 1.6% |
| JNJ FY25 | $94.2B | +6.0% | 67.9% | — | 28.5% | 20.9% |
| LLY FY25 | $65.2B | +44.7% | — | — | 31.7% | — |
| MRK FY25 | $65.0B | +1.3% | — | — | 28.1% | 19.0% |
| ABBV FY25 | $61.2B | +8.6% | — | 24.6% | 6.9% | 29.1% |
| BMY FY25 | $48.2B | -0.2% | — | — | 14.6% | 26.7% |
| TMO FY25 | $44.6B | +3.9% | — | 17.4% | 15.0% | 14.1% |
Source: SEC EDGAR XBRL company facts (10-Q / 10-K), snapshot generated 2026-11-03 for 218 tickers. Q4 values are derived as the 10-K annual less the first nine months, since Q4 is not separately tagged in company facts; cash-flow quarterly values are derived from year-to-date filings the same way. Free cash flow = operating cash flow − capital expenditures. Blank cells mean the filing does not report that line item under a standard US-GAAP tag — nothing is estimated or filled in. Descriptive research, not investment advice. How EarnIQ builds fundamentals.